Peptide Sailing, Join the Grand Event | Congen Pharma Appears at the 10th National Academic Exchange Conference on Cutting-Edge Technologies for Peptide Drug R&D and Mass Production

Publish Time:

2024-11-19

From November 13th to 15th, the 10th National Academic Exchange Conference on Peptide Drug R&D and Large-Scale Production Cutting-Edge Technology was grandly held in Sanya, Hainan. Congen Pharma, dedicated to making sustainable and affordable peptides accessible for human beauty and health, actively participated in this event, engaging with industry colleagues to discuss cooperation and explore the latest R&D achievements and future trends in the peptide field.

At the conference, experts, scholars, entrepreneurs, and R&D personnel from across the country in the peptide drug field gathered together, engaging in in-depth exchanges on recent development trends in peptide drug R&D and large-scale production, focusing on topics such as global peptide drug R&D hotspots and progress, internationalization of the peptide industry and international R&D registration, peptide CMC and PDC, and new methods and processes for peptide synthesis.

Congen Pharma engaged in enthusiastic discussions with attendees, sharing the latest research progress in innovative drug peptide processes, quality research services, and the GLP-1 industrial chain, and creating precious moments of pleasant exchanges.

EMPHASES ^®Innovative liquid-phase peptide synthesis platform, using liquid-phase carriers to replace traditional solid-phase resins, improves reaction speed, shortens reaction time, and increases synthesis efficiency; reduces the use of amino acids, condensing agents, and solvents, reducing three-waste emissions, effectively controlling costs, and attracting much attention. In addition, a series of GLP-1 industrial chain products: Side chains, short peptides, oral enhancers, peptide fragments, etc., have won the favor of on-site customers due to their quality and price advantages.

Sailing the peptide sea, exciting and splendid. Congen Pharma will continue to work hand in hand with industry colleagues to promote technological innovation and development in drug peptides, looking forward to meeting again at the next conference to participate in the grand event!